Biotech Industry News
A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Revolution Medicines Stock: Strong Data, Big Market (Rating Upgrade) (NASDAQ:RVMD)
Revolution Medicines is upgraded to buy as Daraxonrasib delivers practice-changing Phase 3 data in pancreatic ductal adenocarcinoma (PDAC). RVMD's $4B pro forma liquidity supports over two years of aggressive clinical expansion, with cash burn…
Lyell Immunopharma: Undervalued Ahead Of A Major CAR-T Inflection (NASDAQ:LYEL)
Lyell Immunopharma (LYLE) offers asymmetric upside, with ronde-cel showing best-in-class durability and safety in relapsed/refractory LBCL. LYLE trades near cash value, with the market heavily discounting its pipeline despite advanced pivotal…
Rhenman & Partners Asset Management AB Increases Holdings in Adaptive Biotechnologies Corporation $ADPT
Rhenman & Partners Asset Management AB lifted its position in shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 22.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange…
The Quantum Frontier: How Quantum Computing Is Reshaping Our Future
Quantum computing was once considered a distant scientific project that could revolutionize computing. That discussion has shifted drastically today. Quantum technologies have progressed beyond lab trials and theory. Emerging quantum capabilities…
Five Stocks Making Bullish Moves As Market Rebounds
Five companies spanning the gamut of the stock market showed bullish signs this week. In a week dominated by Elon Musk's SpaceX (SPCX) IPO, with a side order of Iran negotiations, these five stocks have all made strong moves, and investors would do…
AeroVironment (AVAV) Invests $15M to Expand Advanced Production in Ohio
AeroVironment Inc. (NASDAQ: AVAV) is one of the most promising mid-cap stocks to buy according to analysts. On June 2, AeroVironment announced plans to invest $15 million to expand its advanced production capabilities in Greene County near Dayton…
Is Corvus Pharmaceuticals, Inc. (CRVS) A Good Stock To Buy Now?
Is CRVS a good stock to buy? We came across a bullish thesis on Corvus Pharmaceuticals, Inc. on Biotech Distilled's Substack. In this article, we will summarize the bulls' thesis on CRVS. Corvus Pharmaceuticals, Inc.'s share was trading at $11.15…
Angel Yeast Releases 2025 Sustainability Report as Company Marks 40th Anniversary
SHANGHAI, June 12, 2026 /CNW/ -- Angel Yeast (SSE: 600298), one of the world's leading yeast manufacturers, recently marked its 40th anniversary with the release of the 2025 Sustainability Report. Structured around four key themes--Stable…
Welcome to swag socialism: New Yorkers waited hours in line for Mamdani's affordable World Cup jerseys
New York City's swag (democratic) socialist renaissance has arrived. Mayor Zohran Mamdani unveiled an affordable Big Apple-themed World Cup jersey — going for about $50 while FIFA's are topping $150 — this week, and people lined up…
Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
COPENHAGEN, Denmark; June 13, 2026 Results from the Phase 2 EPCOREDLBCL-3 trial show fixed-duration epcoritamab monotherapy demonstrated early responses in elderly patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) ineligible for…
This Week's Awesome Tech Stories From Around the Web (Through June 13)
Every week, we scour the web for important, insightful, and fascinating stories in science and technology. Jeff Bezos Wants to Build an ‘Artificial General Engineer' Cade Metz | The New York Times ($) ''All societal wealth is driven by…
Exelixis, Inc. $EXEL Shares Bought by Ieq Capital LLC
Ieq Capital LLC boosted its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 86.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 713,624 shares of the biotechnology company's stock after…
US orders Anthropic to disable AI models for all foreign nationals
The AI firm Anthropic has blocked access to its newly released cutting-edge software, following an order by the United States government. In a blog post published Friday, the company behind the Claude chatbot said government agencies had instructed…
What Does the Bicara Therapeutics CEO's Sale of 15,000 Shares Mean for Investors?
Claire Mazumdar, Chief Executive Officer of Bicara Therapeutics Inc. (BCAX +1.93%), reported the exercise of 15,000 stock options with immediate sale of the resulting common shares on May 18, 2026, as disclosed in the SEC Form 4 filing.
State Street Corp Has $5.30 Billion Holdings in Vertex Pharmaceuticals Incorporated $VRTX
State Street Corp raised its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 0.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 11,689,539 shares of the…
Receive a Daily briefing on Biotech Industry News
Get Started